These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36651756)

  • 21. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis.
    Moore JE; Millar BC
    Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Immune Response to
    Mauch RM; Jensen PØ; Qvist T; Kolpen M; Moser C; Pressler T; Nolasco da Silva MT; Høiby N;
    Front Cell Infect Microbiol; 2022; 12():858398. PubMed ID: 35548464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
    Binder AM; Adjemian J; Olivier KN; Prevots DR
    Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
    Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
    Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
    Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
    BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
    Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
    BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontuberculous mycobacteria in cystic fibrosis.
    Nick JA; Daley CL; Lenhart-Pendergrass PM; Davidson RM
    Curr Opin Pulm Med; 2021 Nov; 27(6):586-592. PubMed ID: 34431787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators.
    Burke A; Thomson RM; Wainwright CE; Bell SC
    Semin Respir Crit Care Med; 2023 Apr; 44(2):287-296. PubMed ID: 36649736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.
    Caverly LJ; Carmody LA; Haig SJ; Kotlarz N; Kalikin LM; Raskin L; LiPuma JJ
    PLoS One; 2016; 11(4):e0153876. PubMed ID: 27093603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent host innate immune response to the smooth-to-rough
    Wheeler EA; Lenhart-Pendergrass PM; Rysavy NM; Poch K; Caceres S; Calhoun KM; Serban K; Nick JA; Malcolm KC
    bioRxiv; 2023 May; ():. PubMed ID: 37293112
    [No Abstract]   [Full Text] [Related]  

  • 33. Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.
    Nick JA; Malcolm KC; Hisert KB; Wheeler EA; Rysavy NM; Poch K; Caceres S; Lovell VK; Armantrout E; Saavedra MT; Calhoun K; Chatterjee D; Aboellail I; De P; Martiniano SL; Jia F; Davidson RM
    Tuberculosis (Edinb); 2023 Jan; 138():102276. PubMed ID: 36417800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.
    Fernández-Caso B; Vázquez R; Alarcón T; Girón R; López-Giménez MR; Domingo D
    Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):323-326. PubMed ID: 31744623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study.
    Saint GL; Thomas MF; Zainal Abidin N; Langley RJ; Brodlie M; McNamara P;
    Arch Dis Child; 2022 May; 107(5):479-485. PubMed ID: 34740877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis.
    Bolden N; Mell JC; Logan JB; Planet PJ
    Paediatr Respir Rev; 2023 Jun; 46():63-70. PubMed ID: 36828670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro.
    Breen P; Zimbric M; Caverly LJ
    PLoS One; 2024; 19(5):e0303516. PubMed ID: 38728330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
    Burke A; Smith D; Coulter C; Bell SC; Thomson R; Roberts JA
    Clin Pharmacokinet; 2021 Sep; 60(9):1081-1102. PubMed ID: 33982266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Patients in Tropical French Reunion Island.
    Ho D; Belmonte O; Andre M; Gazaille V; Perisson C; Gachelin E; Allyn J; Payet A; Coolen-Allou N
    Pediatr Infect Dis J; 2021 Mar; 40(3):e120-e122. PubMed ID: 33427803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.